Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro M. E. MarshallK. KervinM. B. Khazaeli OriginalPaper Pages: S3 - S10
The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines R. B. MyersM. ParkerW. E. Grizzle OriginalPaper Pages: S11 - S13
Antitumour activity of coumarin in prostate and mammary cancer models E. von AngererM. KagerA. Maucher OriginalPaper Pages: S14 - S16
Mode of action of coumarin in immune cells G. J. ZlabingerC. NöhammerJ. E. Menzel OriginalPaper Pages: S17 - S18
Coumarin modulates the cell-cycle progression of an MTV-EJras cell line J. KahnP. PreisA. Tseng Jr. OriginalPaper Pages: S19 - S22
7-Hydroxycoumarin inhibits oncogene-induced transformation of murine fibroblasts R. SeligerH. Pettersson OriginalPaper Pages: S23 - S27
Antibody-based approaches to coumarin analysis D. A. EganB. DeasyR. O'Kennedy OriginalPaper Pages: S28 - S29
Regulation of coumarin 7-hydroxylation in man O. PelkonenA. RautioJ. Hakkola OriginalPaper Pages: S30 - S31
Treatment with coumarin to prevent or delay recurrence of malignant melanoma R. D. ThornesL. DalyA. Tanner OriginalPaper Pages: S32 - S34
Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma J. L. MohlerB. T. WilliamsM. E. Marshall OriginalPaper Pages: S35 - S38
An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin M. E. MarshallJ. L. MohlerG. Cloud OriginalPaper Pages: S39 - S42